284 related articles for article (PubMed ID: 7083176)
1. Induction of antitumor immunity by tumor cells treated with abrin.
Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of astaxanthin and its mode of action.
Jyonouchi H; Sun S; Iijima K; Gross MD
Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to soluble tumor antigens in various stages of tumor growth.
Brannen GE; Santos GW
Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
[TBL] [Abstract][Full Text] [Related]
6. Immunological role of vitamin A and its related substances in prevention of cancer.
Tomita Y
Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
8. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
Toes RE; Blom RJ; van der Voort E; Offringa R; Melief CJ; Kast WM
Cancer Res; 1996 Aug; 56(16):3782-7. PubMed ID: 8706024
[TBL] [Abstract][Full Text] [Related]
9. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
Koyama S; Yoshioka T; Sakita T
Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
Livingston PO; DeLeo AB; Jones M; Oettgen HF
J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
[TBL] [Abstract][Full Text] [Related]
14. Macrophage processing of antigen for induction of tumor immunity.
Brunda MJ; Raffel S
Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
[TBL] [Abstract][Full Text] [Related]
15. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
[TBL] [Abstract][Full Text] [Related]
17. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines.
Yoshida J; Takamura S; Yamaguchi N; Ren LJ; Chen H; Koshimura S; Suzuki S
Jpn J Exp Med; 1989 Aug; 59(4):157-61. PubMed ID: 2601113
[TBL] [Abstract][Full Text] [Related]
19. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
[TBL] [Abstract][Full Text] [Related]
20. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
